1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Generic Markets 18 JANUARY 2016

World Generic Markets 18 JANUARY 2016

  • January 2016
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Existing Legislation Unlikely To Be Used But Threat Remains
Industry Trend Analysis - R&D Spending At 'Historic Low' As Further Patent Changes Loom On The Horizon
Industry Brief - Companies Launch Generic Ortho Tri-Cyclen Lo
Industry Trend Analysis - Momenta Agreement Adds To Momentum Propelling Mylan Into Biosimilar Sphere
Industry Brief - Mylan Files Fluticasone+Salmeterol ANDA
Industry Trend Analysis - Pay-For-Delay Challenges Are Changing The Patent Settlement Landscape
Industry Brief - Hikma Gains FDA Azathiopine sANDA Approval
Industry Brief - Aurobindo Gains FDA Norethindrone Approval
Industry Brief - Lupin Gains Generic Generess Approval
Industry Brief - Mylan Launches Felbamate Tablets
Industry Trend Analysis - Pricing Issues Will Force Pharma Firms To Tread Warily Ahead Of US Elections
Industry Brief - Akorn Launches Buprenorphine/Naloxone Tablets And Tobramycin Injection
Industry Trend Analysis - Marketing Will Be Key To Creating A Viable Biosimilar Etanercept Niche
Industry Brief - Data From Biosimilar Infliximab Study Presented
Industry Brief - Biocad To Supply Anticancer Biosimilars Outside Russia
Industry Trend Analysis - Phosphagenics Looks To Revitalise Stalled Project
Industry Brief - Sorrento Biosimilars Show Positive Phase III Results
Industry Brief - Yabao And Sciecure Enter Generic Collaboration Agreement
Industry Brief - BioQ And Cipla Enter Ropivacaine Agreement
Industry Brief - Mylan Launches Ledipasvir/Sofosbuvir In India
Industry Brief - Torrent Launches Adalimumab Biosimilar
Industry Brief - Xbrane Enters Ranibizumab Deal With Helvetic BioPharma

Table Of Contents

World Generic Markets 18 JANUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.